- Why are Traders Bullish on This Food Company?
- Profiting From Natural Gas: Strategists
- 3 Hot Mid-Cap Stock Picks: Portfolio Manager
- 'Nice Opportunities' in Health Care Sector: Stock Picker
- Stocks To Play With Health Reform: Analysts
- 4 Tech Stocks For This Holiday Season: Analyst
- Art Cashin: I'm Still Skeptical About Markets
- Rockwell Automation Earnings: What Options Are Saying
- Gold Will Touch Higher Lows and Higher Highs: Analyst
- Correction Coming When Fed Ends 'Easy Money': Market Pro
MOST SHARED
- Obama Sees Strains Unless US, China Balance Growth
- Can Apple Top Microsoft as Most Valuable Tech Firm?
- European Commission Objects to Sun Micro-Oracle Deal
- Future of Marketing
- Mad Mail: Buy the Berkshire Hathaway Split?
- Cramer: 5 Stocks to Play the Next Bull Run
- A Year on, China's Stimulus Postpones its Problems
- JPMorgan Lifts Salary Freeze Amid Recovery
- Framed for Porn – By a PC Virus
- Why Google is Paying $750 Million for Ad Mob
- Warren Buffett to Sell Stakes In Union Pacific & Norfolk Southern
- Nov. 9: Unusual Volume Leaders
- The Battered Businesses Behind Housing
- Modern Warfare 2's Record-Breaking Launch
- Merck’s Mega-Monday Morning
- Why are Traders Bullish on This Food Company?
- Profiting From Natural Gas: Strategists
- S&P Stocks Trading at New 52-Week Highs
- Peak Oil Closer Than IEA Forecasts Show: Report
- UK Most at Risk of Losing Top Credit Rating: Fitch
- GM CEO Starts Charm Tour at Opel in Germany
- Vodafone Extends Cost-Cutting Scheme, Hits Targets
- Bad Debt Weighs on Barclays Earnings
- HSBC Operating Profit Beats, US Bad Debts Slip
- Fed's Tarullo Backs Surcharges to Limit Bank Size
- Look Ahead: 'Risk On' Sentiment Could Fuel Rally Further
- 'Modern Warfare 2': Biggest Entertainment Event?
RSS FEED
CNBC Stock Blog
Cost containment may spell trouble for much of the health-care sector, but Charles Boorady, healthcare providers analyst for Citigroup, says it's likely to spell success for pharmacy benefits managers.
"A couple of things will likely get signed into law in 2009," he said. "One is legislation to facilitate getting biotech generic drugs to the market; we think the PBMs are beneficiaries of that." (See his full comments in the video)
He sees the fallout from another trend benefiting the benefits managers.
"We also think they'll continue to pay doctors a 2 percent bonus to write prescriptions electronically," he said. "As you know, doctors mostly write these prescriptions by hand; 20 percent of prescriptions go unfilled; if they write them electronically, they're more likely to get filled, and they're more likely to get filled by mail-order PBMs."
Recommendations:
Boorady's list includes UnitedHealth Group [UNH
Loading...
()
], Wellpoint [WLP
Loading...
()
], Medco Health Solutions [MHS
Loading...
()
], and Express Scripts [ESRX
Loading...
()
].
Disclosures:
UnitedHealth Group, Wellpoint, Medco Health Solutions, and Express Scripts are all investment banking clients of Boorady's firm. In addition, his firm makes a market in shares of Express Scripts.









